Lage H - Search Results

1

Reversal of breast cancer resistance protein-mediated drug resistance by tryprostatin A.

Woehlecke H, Osada H, Herrmann A, Lage H. Woehlecke H, et al. Among authors: lage h. Int J Cancer. 2003 Dec 10;107(5):721-8. doi: 10.1002/ijc.11444. Int J Cancer. 2003. PMID: 14566821

2

Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2).

Woehlecke H, Pohl A, Alder-Baerens N, Lage H, Herrmann A. Woehlecke H, et al. Among authors: lage h. Biochem J. 2003 Dec 1;376(Pt 2):489-95. doi: 10.1042/BJ20030886. Biochem J. 2003. PMID: 12946267 Free PMC article.

3

Transport of phosphatidylserine via MDR1 (multidrug resistance 1)P-glycoprotein in a human gastric carcinoma cell line.

Pohl A, Lage H, Müller P, Pomorski T, Herrmann A. Pohl A, et al. Among authors: lage h. Biochem J. 2002 Jul 1;365(Pt 1):259-68. doi: 10.1042/BJ20011880. Biochem J. 2002. PMID: 12071854 Free PMC article.

4

Association of genomic imbalances with drug resistance and thermoresistance in human gastric carcinoma cells.

Tönnies H, Poland J, Sinha P, Lage H. Tönnies H, et al. Among authors: lage h. Int J Cancer. 2003 Mar 1;103(6):752-8. doi: 10.1002/ijc.10905. Int J Cancer. 2003. PMID: 12516094

5

Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells.

Materna V, Liedert B, Thomale J, Lage H. Materna V, et al. Among authors: lage h. Int J Cancer. 2005 Jun 20;115(3):393-402. doi: 10.1002/ijc.20899. Int J Cancer. 2005. PMID: 15688364

6

High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs.

Lage H, Aki-Sener E, Yalcin I. Lage H, et al. Int J Cancer. 2006 Jul 1;119(1):213-20. doi: 10.1002/ijc.21792. Int J Cancer. 2006. PMID: 16450374

7

Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.

Stein U, Lage H, Jordan A, Walther W, Bates SE, Litman T, Hohenberger P, Dietel M. Stein U, et al. Among authors: lage h. Int J Cancer. 2002 Feb 20;97(6):751-60. doi: 10.1002/ijc.10131. Int J Cancer. 2002. PMID: 11857350

8

Multiple mechanisms confer different drug-resistant phenotypes in pancreatic carcinoma cells.

Lage H, Dietel M. Lage H, et al. J Cancer Res Clin Oncol. 2002 Jul;128(7):349-57. doi: 10.1007/s00432-002-0349-y. Epub 2002 Jun 26. J Cancer Res Clin Oncol. 2002. PMID: 12136248

9

Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.

Györffy B, Surowiak P, Kiesslich O, Denkert C, Schäfer R, Dietel M, Lage H. Györffy B, et al. Among authors: lage h. Int J Cancer. 2006 Apr 1;118(7):1699-712. doi: 10.1002/ijc.21570. Int J Cancer. 2006. PMID: 16217747

10

Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference.

Stege A, Priebsch A, Nieth C, Lage H. Stege A, et al. Among authors: lage h. Cancer Gene Ther. 2004 Nov;11(11):699-706. doi: 10.1038/sj.cgt.7700751. Cancer Gene Ther. 2004. PMID: 15375376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters